France's Sanofi Looking At 1-2 Billion Euros Worth of Acquisitions Per Year

French pharmaceutical group Sanofi is looking to make annual acquisitions of up to 2 billion euros to boost its priority sectors, managing director Chris Viehbacher told Monday's Le Figaro newspaper.

“We are going to keep reinforcing the growth platforms to a tune of 1 to 2 billion euros (US$1.4-2.7 billion) a year in acquisitions,” he said.

The designated areas are diabetes treatment, vaccines, animal health, self-medication, emerging markets, rare diseases...